
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.
(00:32)
Would you mind telling us a little bit about yourself and your background?
(01:58)
Would you give us an overview of membranous nephropathy?
(07:14)
Could you tell us a little bit about this new assay?
(14:29)
Could you give a little example of how a clinician might use this information to treat their patients differently than how they would've in the past?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab

Closing a Diagnostic Gap for Chronic Diarrhea
Answers from the Lab

Unlock the Full Potential of Research Data
Answers from the Lab

A New Mindset for Leading Through Change
Answers from the Lab

Key Components of Innovation Success
Answers from the Lab